Artificial Bone Market

Artificial Bone Market, By Material (Ceramics, Composite, Polymer, Hydroxyapatite, Others), By Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma and Extremities), By End User (Hospitals, Specialty Clinics, Research and Academic Institutes ), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Artificial bone is a bone-like material created in a laboratory that can be used in bone grafts to replace human bone that is lost due to severe fractures or bone and joint diseases. Artificial bones are made from materials such as ceramics, composites, polymers, hydroxyapatite, and others. Artificial bones are mostly used for the surgeries of spinal fusion, dental therapies, craniomaxillofacial surgery, joint reconstruction, and trauma and extremities. A bone fracture, which is a complete or partial break in the bone, is a very common condition that has more than three million U.S. cases per year. Human bones have the ability to regenerate themselves through the cycles of bone resorption and bone formation. The cell responsible for bone resorption is the osteoclast, while the cell responsible for bone formation is the osteoblast. The human body can regenerate fractured bones. However, if damage to bones is caused by a disease or severe injury, it becomes difficult for the body to repair itself. When the human body is unable to regenerate the lost bone tissue, surgeons come in and replace the missing bone using autografts, allografts, and synthetic grafts (artificial bone). When comparing artificial bone to autograft and allograft, it is less invasive and more biocompatible since it avoids the risk of unknown viral infections.

Market Dynamics

Increasing launch of artificial bones by the key players in the market are expected to drive the growth of the global artificial bone market over the forecast period. For instance, in March 2022, Molecular Matrix, Inc., a pre-clinical-stage biotechnology company intended to facilitate advanced 3D tissue engineering services, announced the launch of its Osteo-P Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system. Osteo-P BGS is made using Molecular Matrix, Inc.’s hyper-crosslinked carbohydrate polymer (HCCP) technology platform, for bone repair and regeneration.

Key features of the study:

• This report provides an in-depth analysis of the global artificial bone market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global artificial bone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation, NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM, OssDsign AB, Halma plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global artificial bone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial bone market

Artificial Bone Market Detailed Segmentation:

• By Material:
• Ceramics
• Composite
• Polymer
• Hydroxyapatite
• Others
• By Application:
• Spinal Fusion
• Dental
• Craniomaxillofacial
• Joint Reconstruction
• Trauma and Extremities
• By End User:
• Hospitals
• Specialty Clinics
• Research and Academic Institutes
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Medtronic Plc.
• Johnson & Johnson
• Baxter International Inc.
• Smith & Nephew plc
• Stryker Corporation
• NuVasive, Inc.
• Allosource
• Curasan, Inc.
• Ziacom Medical SLU
• Orthofix International N.V.
• Biomatlante
• DSM
• OssDsign AB
• Halma plc